Precigen Inc (PGEN) FY2025Q3 Earning Prediction

11/13 05:00:00

After Hours

Precigen Inc (PGEN) is set to release its earnings performance on 11/13 05:00:00 in After Hours trading. Consensus forecasts predict a revenue of 500.00K and an earnings per share (EPS) of -0.08 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueBEAT

500.00K

2.92M

+484.40%

EPSMISS

-0.08

-1.06

-1225.00%

AI Summary

Report

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

PGEN Transcript

Precigen, Inc. (PGEN) Q3 2025 Earnings Call Transcript

Positive11-13

The earnings call summary and Q&A reveal positive aspects: expansion plans, optimistic guidance on reaching cash breakeven, and strong market momentum for PAPZIMEOS. Despite some risks like cold chain logistics and regulatory compliance, the company’s financial health is stable with $123.6 million in cash and investments. The Q&A reassures on patient reimbursement and market adoption. The stock price is likely to react positively in the short-term, driven by optimistic guidance and market expansion strategies.

Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript

Unknown3-19

The earnings call presents a mixed sentiment. While there are positive elements like strong cash position and potential revenue from PRGN-2012, there are concerns over increased net loss and supply chain risks. The Q&A highlights FDA interactions and market strategy, but management's evasiveness on key timelines adds uncertainty. Overall, the financial health and strategic outlook balance out the negatives, leading to a neutral sentiment prediction.

Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript

Unknown3-19

The earnings call reflects mixed signals: strong cash position and anticipated demand for PRGN-2012 suggest positive sentiment. However, increased net loss, operational risks, and competitive pressures temper optimism. The Q&A highlights management's cautious communication about FDA interactions and market capture, which adds uncertainty. Considering these factors, the stock price is expected to remain stable.

Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript

Unknown8-14

The earnings call highlights significant financial concerns, including a large net loss and workforce reduction, which could affect operational capacity. The equity issuance and cash on hand provide limited runway. Positive aspects like the PRGN-2012 progress and global ambitions are overshadowed by vague management responses and market access challenges. The Q&A session reveals analyst concerns about FDA meetings and global strategy clarity. Overall, the negative financial outlook and uncertainties suggest a negative stock price movement in the short term.

PGEN Report

Frequently Asked Questions

What is the Precigen Inc FY2025Q3 Earnings Release Date and Time?

Precigen Inc (PGEN) is scheduled to release its FY2025Q3 earnings report onNov 13, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Precigen Inc FY2025Q3 Revenue and EPS?

Analysts' consensus predicts 500.00K in revenue and an EPS of -0.08 for Precigen Inc's FY2025Q3.

What Does Intellectia's AI Predict for Precigen Inc FY2025Q3 Earnings?

Intellectia's exclusive AI algorithms forecast a forPrecigen Inc's FY2025Q3 earnings, with a prediction date of Nov 13, 2025. Precigen Inc

How Can I Use This Earnings Prediction to Trade PGEN Stock?

Leverage Intellectia's AI forecast to position trades ahead of theNov 13, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Precigen Inc FY2025Q3?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!